# FDA recall D-002-2013

> **McKesson Packaging Services** · Class III · drug recall initiated 2012-03-29.

## Product

buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey  08512; blister barcode N (01)003 63739 450 10 3, Dist By: McKesson Packaging, Concord, NC  28027; NDC 63739-450-10, carton barcode 6373945010.

## Reason for recall

Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-002-2013
- **Recalling firm:** McKesson Packaging Services
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-03-29
- **Report date:** 2012-10-10
- **Termination date:** 2013-04-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Concord, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-002-2013

## Citation

> AI Analytics. FDA recall D-002-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-002-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
